A federal grant will fund a new post doctorate training program in cancer nanotechnology at the University of North Carolina at Chapel Hill. The National Institute of Health grant of $1.8 million creates a postdoctoral training program within the UNC Eshelman School of Pharmacy’s Center for Nanotechnology in Drug Delivery.
Nanotechnology – which deals with the ultra-small – may have applications in both the treatment and the diagnosis of cancer, according to Andrew Wang, M.D., associate professor in the UNC School of Medicine Department of Radiation Oncology, and the program’s co-director. He said the program’s interdisciplinary nature will set it apart.
“We think the trainees coming out of this program will be very well-rounded, and will be much better equipped to take on the next set of challenges; the cutting-edge research questions,” Wang said in a statement, explaining that program will offer instruction in clinical oncology, cancer biology as well as in nanotechnology.
“We aim to attract trainees with diverse backgrounds, not just in chemical engineering, which dominates the landscape right now. We also want to train cancer biologists and clinician scientists, who will be critical in furthering nanomedicine research.”
The program will be run in collaboration with the Carolina Institute for Nanomedicine, the Carolina Center for Cancer Nanotechnology Excellence and the UNC Lineberger Comprehensive Ca
